A model for 3-dimensional growth of bladder cancers to investigate cell-matrix interactions

Urologic Oncology: Seminars and Original Investigations

Volumn 21, Issue 4, 2003, Pages 255-261

  Kyker, Kimberly D ^a   Culkin, Daniel J ^a   Hurst, Robert E ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

3 dimensional culture; Bladder cancer; Invasion; Matrigel; SIS

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; CADHERIN; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; BLADDER CANCER; CANCER CELL; CANCER CELL CULTURE; CELL GROWTH; CELL INTERACTION; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE MODEL; EPIGENETICS; EXTRACELLULAR MATRIX; FETAL CALF SERUM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; BLADDER TUMOR; CANCER INVASION; CELL ADHESION; CELL CULTURE; CYTOSKELETON; ENZYME IMMUNOASSAY; METABOLISM; PAPILLOMA; PATHOLOGY; TRANSITIONAL CELL CARCINOMA;

BETA CATENIN; CADHERINS; CARCINOMA, TRANSITIONAL CELL; CELL ADHESION; CYTOSKELETAL PROTEINS; CYTOSKELETON; EXTRACELLULAR MATRIX; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM INVASIVENESS; PAPILLOMA; PHENOTYPE; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 2142646423     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-1439(02)00279-X     Document Type: Article

References (28)

1. Smith B.A., Kennedy W.J., Harnden P., Selby P.J., Trejdosiewicz L.K., Southgate J. Identification of genes involved in human urothelial cell-matrix interactions implications for the progression pathways of malignant urothelium. Cancer Res. 61:2001;1678-1685
2. Chung L.W., Davies R. Prostate epithelial differentiation is dictated by its surrounding stroma. Mol Biol Rep. 23:1996;13-19
3. Sannes P.L., Khosla J., Li C.M., Pagan I. Sulfation of extracellular matrices modifies growth factor effects on type II cells on laminin substrata. Am J Physiol Lung Cell Mol Physiol. 275:1998;L701-L708
4. Heldin C., Betscholz C., Claesson-Welsh I., Westermark B. Subversion of growth regulatory pathways in malignant transformation. Biochim Biophys Acta. 907:1987;219-244
5. Aeschlimann D., Thomazy V. Protein crosslinking in assembly and remodelling of extracellular matrices the role of transglutaminases. Connect Tissue Res. 41:2000;1-27
6. Huang S., Ingber D.E. The structural and mechanical complexity of cell-growth control. Nat Cell Biol. 1:1999;E131-E138
7. Iozzo R.V. Proteoglycans and neoplasia. Cancer Metastasis Rev. 7:1988;39-50
8. Vaccari M., Silingardi P., Argnani A., et al. In vitro effects of fenretinide on cell-matrix interactions. Anticancer Res. 20:2000;3059-3066
9. Farina A.R., Coppa A., Tiberio A., et al. Transforming growth factor-beta1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity. Int J Cancer. 75:1998;721-730
10. Strohmaier A.R., Spring H., Spiess E. Three-dimensional analysis of the substrate-dependent invasive behavior of a human lung tumor cell line with a confocal laser scanning microscope. Histochem Cell Biol. 105:1996;179-185
11. Stadler E., Dziadek M. Extracellular matrix penetration by epithelial cells is influenced by quantitative changes in basement membrane components and growth factors. Exp Cell Res. 229:1996;360-369
12. Guruswamy S., Lightfoot S., Gold M.A., et al. Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma. J Natl Cancer Inst. 93:2001;516-525
13. Kropp B.P., Ludlow J.K., Spicer D., et al. Rabbit urethral regeneration using small intestinal submucosa onlay grafts. Urology. 52:1998;138-142
14. Badylak S.F., Record R., Lindberg K., Hodde J., Park K. Small intestinal submucosa a substrate for in vitro cell growth. J Biomater Sci Polym Ed. 9:1998;863-878
15. Hurst R., Kyker K., Bonner R., Hemstreet G.P. Integrins and serum regulate suppression or expression of the malignant bladder cancer phenotype in three-dimensional gels. Proc Amer Assoc Cancer Res. 42:2001;55
16. Mialhe A., Levacher G., Champelovier P., et al. Expression of E-, P-, n-cadherins and catenins in human bladder carcinoma cell lines. J Urol. 164:2000;826-835
17. Fujisawa M., Miyazaki J., Takechi Y., Arakawa S., Kamidono S. The significance of E-cadherin in transitional-cell carcinoma of the human urinary bladder. World J Urol. 14:(Suppl 1):1996;S12-S15
18. Wakatsuki S., Watanabe R., Saito K., et al. Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder. Cancer Lett. 103:1996;11-17
19. Morton R.A. Jr, Ewing C.M., Watkins J.J., Isaacs W.B. The E-cadherin cell-cell adhesion pathway in urologic malignancies. World J Urol. 13:1995;364-368
20. Sellin J.H., Umar S., Xiao J., Morris A.P. Increased beta-catenin expression and nuclear translocation accompany cellular hyperproliferation in vivo. Cancer Res. 61:2001;2899-2906
21. Morin P.J. Beta-catenin signaling and cancer. BioEssays. 21:1999;1021-1030
22. Shimazui T., Schalken J.A., Giroldi L.A., et al. Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and pl20cas) in bladder tumors. Cancer Res. 56:1996;4154-4158
23. Kan M., Furukawa A., Aki M., Kanayama H., Kagawa S. Expression of CD44 splice variants in bladder cancer. Int J Urol. 2:1995;295-301
24. Saito T., Kimura M., Kawasaki T., Sato S., Tomita Y. Correlation between integrin alpha 5 expression and the malignant phenotype of transitional cell carcinoma. Br J Cancer. 73:1996;327-331
25. Liebert M., Washington R., Wedemeyer G., Carey T.E., Grossman H.B. Loss of co-localization of alpha 6 beta 4 integrin and collagen VII in bladder cancer. Am J Pathol. 144:1994;787-795
26. Grossman H.B., Washington R.W. Jr, Carey T.E., Liebert M. Alterations in antigen expression in superficial bladder cancer. J Cell Biochem Suppl. 161:1992;63-68
27. Syrigos K.N., Harrington K.J., Pignatelli M. Role of adhesion molecules in bladder cancer an important part of the jigsaw. Urology. 53:1999;428-434
28. Elstad C.A., Meadows G.G., Aslakson C.J., Starkey J.R. Evidence for nutrient modulation of tumor phenotype impact of tyrosine and phenylalanine restriction. Adv Exp Med Biol. 354:1994;171-183